Gables Capital Management Inc. Dynavax Technologies Corp Transaction History

Gables Capital Management Inc.

$204 Million
Q4 2024

A detailed history of Gables Capital Management Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Gables Capital Management Inc. holds 1,750 shares of DVAX stock, worth $23,100. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,750

Previous 2,000 12.5%

Holding current value

$23,100

Previous $22,000 -0.0%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$10.28 - $13.66 $2,570 - $3,415	-250 Reduced 12.5%	1,750 $22,000
Q2 2024 Aug 07, 2024	SELL	$10.73 - $12.58 $5,096 - $5,975	-475 Reduced 19.19%	2,000 $22,000
Q3 2023 Nov 02, 2023	SELL	$12.64 - $14.99 $10,744 - $12,741	-850 Reduced 25.56%	2,475 $36,000
Q2 2023 Aug 02, 2023	SELL	$9.85 - $13.17 $42,601 - $56,960	-4,325 Reduced 56.54%	3,325 $42,000
Q1 2023 May 03, 2023	SELL	$9.44 - $11.88 $61,360 - $77,220	-6,500 Reduced 45.94%	7,650 $75,000
Q4 2022 Feb 03, 2023	SELL	$10.27 - $13.29 $10,783 - $13,954	-1,050 Reduced 6.91%	14,150 $150,000
Q3 2022 Oct 31, 2022	SELL	$9.93 - $17.44 $18,867 - $33,136	-1,900 Reduced 11.11%	15,200 $159,000
Q1 2022 May 02, 2022	SELL	$9.75 - $14.44 $6,337 - $9,386	-650 Reduced 3.66%	17,100 $185,000
Q4 2021 Feb 09, 2022	SELL	$13.17 - $20.94 $10,206 - $16,228	-775 Reduced 4.18%	17,750 $250,000
Q3 2021 Nov 12, 2021	SELL	$9.16 - $19.83 $26,564 - $57,506	-2,900 Reduced 13.54%	18,525 $356,000
Q2 2021 Aug 03, 2021	SELL	$7.25 - $10.99 $69,600 - $105,504	-9,600 Reduced 30.94%	21,425 $211,000
Q1 2021 May 12, 2021	SELL	$4.57 - $11.18 $914 - $2,236	-200 Reduced 0.64%	31,025 $305,000
Q4 2020 Feb 03, 2021	SELL	$3.73 - $5.6 $15,852 - $23,800	-4,250 Reduced 11.98%	31,225 $139,000
Q3 2020 Nov 12, 2020	SELL	$4.32 - $11.7 $6,696 - $18,135	-1,550 Reduced 4.19%	35,475 $153,000
Q2 2020 Jul 30, 2020	SELL	$2.94 - $9.1 $24,990 - $77,350	-8,500 Reduced 18.67%	37,025 $328,000
Q1 2020 May 07, 2020	SELL	$2.27 - $6.2 $21,962 - $59,985	-9,675 Reduced 17.53%	45,525 $163,000
Q4 2019 Feb 10, 2020	SELL	$3.46 - $6.93 $30,621 - $61,330	-8,850 Reduced 13.82%	55,200 $317,000
Q3 2019 Oct 30, 2019	BUY	$2.69 - $4.85 $10,760 - $19,400	4,000 Added 6.66%	64,050 $231,000
Q2 2019 Jul 31, 2019	SELL	$3.65 - $7.89 $57,305 - $123,873	-15,700 Reduced 20.73%	60,050 $239,000
Q1 2019 Apr 30, 2019	SELL	$7.08 - $12.09 $41,064 - $70,122	-5,800 Reduced 7.11%	75,750 $553,000
Q4 2018 Feb 08, 2019	BUY	$8.14 - $13.28 $13,431 - $21,912	1,650 Added 2.07%	81,550 $746,000
Q3 2018 Nov 05, 2018	BUY	$11.85 - $16.0 $183,675 - $248,000	15,500 Added 24.07%	79,900 $0
Q2 2018 Aug 03, 2018	BUY	$15.15 - $20.75 $263,897 - $361,444	17,419 Added 37.08%	64,400 $994,000
Q1 2018 May 17, 2018	BUY	$14.65 - $19.9 $688,271 - $934,921	46,981 New	46,981 $933,000

Others Institutions Holding DVAX

# of Institutions

285

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.67B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gables Capital Management Inc. with notifications on news.

Account

Gables Capital Management Inc. Dynavax Technologies Corp Transaction History